New Strategies for Managing Diabetic Retinopathy - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

New Strategies for Managing Diabetic Retinopathy

  • By

  • Omar Saeed, MPH

  • Veeral S. Sheth, MD, MBA, FACS

  • May 1, 2026

  • 12 min

Share

Clinical Scorecard: New Strategies for Managing Diabetic Retinopathy

At a Glance

CategoryDetail
Condition
Key MechanismsInvolves microvascular pathology, inflammation, and vascular destabilization, contributing to vision loss.
Target Population
Care Setting

Key Highlights

  • Emerging therapies, including Susvimo and gene therapy, are reshaping management strategies.

Guideline-Based Recommendations

Diagnosis

  • Utilize multimodal imaging, including OCT and fundus photography, for early detection and monitoring of DR.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Emerging therapies like Susvimo and gene therapy may reduce treatment frequency and improve outcomes, but further studies are needed to confirm long-term efficacy.

        Clinical Best Practices

        • Adopt biosimilars to enhance treatment adherence and reduce costs.
        • Incorporate advanced imaging techniques into routine practice for better disease management.
        • Stay updated on ongoing clinical trials and emerging therapies for DR.
        • Educate patients on new therapies and their potential benefits and risks.

        Related Resources & Content

        Original Source(s)

        New Strategies for Managing Diabetic Retinopathy

        • by Omar Saeed, MPH, Veeral S. Sheth, MD, MBA, FACS

        • May 1, 2026

        Related Content

        Correction: Stem-like CD4 T cells in tumors: an emerging framework for antitumor immunity

        Vaccinating girls, abandoning women: the financing asymmetry between HPV immunization and the cervical cancer treatment cascade in low- and middle-income countries

        AI-Designed Binder Improves CAR T Cell Activity in Mice

        Researchers screened 1,758 de novo protein binders and identified design features that influence CAR T cell activation, specificity, and tumor control

        • September 15, 2026

        • 3 min